<p>Brazilian health regulator Anvisa on Monday said it had canceled a clinical study for the Covaxin vaccine for Covid-19 developed by India's Bharat Biotech, amid allegations of irregularities in the government's efforts to buy millions of doses of the shot.</p>.<p><strong>Read | <a href="https://www.deccanherald.com/business/business-news/bharat-biotech-terminates-covaxin-deal-with-brazils-precisa-1012024.html" target="_blank">Bharat Biotech terminates Brazilian Covaxin deal</a></strong></p>.<p>Bharat on Friday said it had terminated a memorandum of understanding with the local partner company acting as its intermediary in Brazil, with Anvisa saying on Monday that the trials could not go forward as a result and would be canceled.</p>.<p>Anvisa had previously suspended the trials temporarily.</p>
<p>Brazilian health regulator Anvisa on Monday said it had canceled a clinical study for the Covaxin vaccine for Covid-19 developed by India's Bharat Biotech, amid allegations of irregularities in the government's efforts to buy millions of doses of the shot.</p>.<p><strong>Read | <a href="https://www.deccanherald.com/business/business-news/bharat-biotech-terminates-covaxin-deal-with-brazils-precisa-1012024.html" target="_blank">Bharat Biotech terminates Brazilian Covaxin deal</a></strong></p>.<p>Bharat on Friday said it had terminated a memorandum of understanding with the local partner company acting as its intermediary in Brazil, with Anvisa saying on Monday that the trials could not go forward as a result and would be canceled.</p>.<p>Anvisa had previously suspended the trials temporarily.</p>